Idebenone
Idebenone is a pharmaceutical drug with 25 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
7
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.5%
19 of 21 finished
9.5%
2 ended early
1
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Clinical Trials (25)
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Study of the Therapeutic Effects of Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment With Kidney Deficiency and Phlegm Stasis
Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients
Post Authorisation Safety Study With Raxone in LHON Patients
Idebenone for Primary Progressive Multiple Sclerosis
Symptomatic Therapy for Patients With Huntington's Disease
Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)
Idebenone to Treat Friedreich's Ataxia
Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25